The above evidence demonstrates a unique invasive-promoting role for the SRGN/YAP/CRISPLD2 axis in HCC cells, potentially offering new insights into the molecular mechanisms underlying tumorigenesis and novel therapeutic strategies. This evidence concerns the gene CRISPLD2 and hepatocellular carcinoma.